You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III neuroendocrine carcinoma of the skin

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II Trial in Australia (Avelumab, Placebo)

Recruiting
  • Merkel Cell Carcinoma
  • +5 more
  • Port Macquarie, New South Wales, Australia
  • +17 more
Aug 30, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Patients With Neuroendocrine Cancer of the Cervix

Recruiting
  • Cervical Large Cell Neuroendocrine Carcinoma
  • +21 more
  • Follow-Up
  • Medical Chart Review
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

Not yet recruiting
  • Papillary Renal Cell Carcinoma
  • (no location specified)
Nov 24, 2023

Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung Trial (LB2102)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Large Cell Neuroendocrine Carcinoma of the Lung
  • LB2102
  • (no location specified)
Jan 10, 2023

Renal Cell Carcinoma Trial (Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Sep 11, 2023

Merkel Cell Carcinoma, Neuroendocrine Carcinoma of the Skin, Trabecular Carcinoma of the Skin Trial in Tampa (Lenvatinib Oral

Recruiting
  • Merkel Cell Carcinoma
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 30, 2022

Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV, Merkel Cell Carcinoma Trial (IFx-Hu2.0)

Available
  • Cutaneous Melanoma, Stage III
  • +3 more
  • IFx-Hu2.0
  • (no location specified)
Aug 5, 2022

Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • without concurrent cisplatin chemotherapy
  • with concurrent cisplatin chemotherapy
  • Fuzhou, Fujian, China
    Department of radiation oncology, Fujian cancer hospital
Oct 18, 2023

Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)

Active, not recruiting
  • Oncology
  • Neuroendocrine Carcinoma
  • Liposomal Irinotecan
  • +3 more
  • Glasgow, United Kingdom
  • +3 more
Dec 2, 2022

Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)

Not yet recruiting
  • Squamous Cell Carcinoma of the Skin
  • Carrilizumab with albumin-binding paclitaxel
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
May 23, 2023

Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma

Recruiting
  • Bladder Small Cell Neuroendocrine Carcinoma
  • +16 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 23, 2022

Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)

Not yet recruiting
  • Small Cell Lung Carcinoma
  • Neuroendocrine Neoplasms
  • BI 764532
  • (no location specified)
May 22, 2023

Recurrent Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Stage I Skin Cancer Trial in Los Angeles,

Recruiting
  • Recurrent Skin Squamous Cell Carcinoma
  • +4 more
  • Cemiplimab
  • Resection
  • Los Angeles, California
  • +2 more
Nov 12, 2022

Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 3, 2022

Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic

Not yet recruiting
  • Metastatic Malignant Neoplasm in the Viscera
  • +4 more
  • Lutetium Lu 177 Dotatate
  • (no location specified)
Jan 25, 2023

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

Recruiting
  • Advanced Colorectal Carcinoma
  • +15 more
  • Fermented Wheat Germ Extract
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jul 26, 2023

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +12 more
  • Biopsy
  • +8 more
  • (no location specified)
Jun 8, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (mobile platform or not mobile platform)

Recruiting
  • Nasopharyngeal Carcinoma
  • mobile platform or not mobile platform
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Apr 17, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 17, 2023

Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

Active, not recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +35 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +7 more
Jan 3, 2023

NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Sugemalimab and Chemotherapy
  • Changsha, China
    Hunan Cancer Hospital
Jul 7, 2023

NSCLC Trial in Beijing

Recruiting
  • NSCLC
    • Beijing, China
      Yuyan Wang
    Oct 10, 2023

    Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell

    Not yet recruiting
    • Clinical Stage III Merkel Cell Carcinoma AJCC v8
    • +5 more
    • (no location specified)
    Jul 13, 2023